What treatment would you consider for metastatic urachal carcinoma following progression on FOLFOX and FOLFIRI?  

Molecular profiling revealed no targetable alterations, however tumor mutational burden was >10 mut/Mb.



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at University of Washington School of Medicine
Great comments by the expert @Guru Sonpavde; regar...
Sign in or Register to read more